Search research articles
Contact Us
Filters
Showing results (71-80 of 83) with videos related to
Page
of 9
Sort By:
The American Journal of Cardiology
|
July 1, 1985
Limitations, risks and complications of laser recanalization: a cautious approach warranted
G Lee, R M Ikeda, M C Chan, et al.
Journal of Medicinal Chemistry
|
October 28, 2005
Scaffold hopping with molecular field points: identification of a cholecystokinin-2 (CCK2) receptor pharmacophore and its use in the design of a prototypical series of pyrrole- and imidazole-based CCK2 antagonists
Caroline M R Low, Ildiko M Buck, Tracey Cooke, et al.
Arquivos De Neuro-Psiquiatria
|
April 12, 2001
[Continuing education in in neurology through the INTERNET]
O M Takayanagui, G D Rabello, M V Ribeiro, et al.
Hepatology (Baltimore, Md.)
|
June 10, 1998
Detection of reovirus RNA in hepatobiliary tissues from patients with extrahepatic biliary atresia and choledochal cysts
K L Tyler, R J Sokol, S M Oberhaus, et al.
Organic & Biomolecular Chemistry
|
March 23, 2007
Substituent effects on aromatic stacking interactions
Scott L Cockroft, Julie Perkins, Cristiano Zonta, et al.
Chest
|
March 1, 1996
Correlative assessment of morphologic, immunophenotypic, and genetic changes in bronchial epithelium of tobacco smokers
W A Franklin, S Todd, R M Gemmill, et al.
Journal of Medicinal Chemistry
|
March 31, 2006
Novel, achiral 1,3,4-benzotriazepine analogues of 1,4-benzodiazepine-based CCK(2) antagonists that display high selectivity over CCK(1) receptors
Iain M McDonald, Carol Austin, Ildiko M Buck, et al.
Journal of Medicinal Chemistry
|
September 14, 2007
Discovery and characterization of novel, potent, non-peptide parathyroid hormone-1 receptor antagonists
Iain M McDonald, Carol Austin, Ildiko M Buck, et al.
Journal of Medicinal Chemistry
|
October 28, 2005
Optimization of the in vitro and in vivo properties of a novel series of 2,4,5-trisubstituted imidazoles as potent cholecystokinin-2 (CCK2) antagonists
Ildiko M Buck, James W Black, Tracey Cooke, et al.
Cell Stem Cell
|
March 7, 2020
MAP4K4 Inhibition Promotes Survival of Human Stem Cell-Derived Cardiomyocytes and Reduces Infarct Size In Vivo
Lorna R Fiedler, Kathryn Chapman, Min Xie, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 83) with videos related to
Sort By:
Page
of 9
The American Journal of Cardiology
|
July 1, 1985
Limitations, risks and complications of laser recanalization: a cautious approach warranted
G Lee, R M Ikeda, M C Chan, et al.
Journal of Medicinal Chemistry
|
October 28, 2005
Scaffold hopping with molecular field points: identification of a cholecystokinin-2 (CCK2) receptor pharmacophore and its use in the design of a prototypical series of pyrrole- and imidazole-based CCK2 antagonists
Caroline M R Low, Ildiko M Buck, Tracey Cooke, et al.
Arquivos De Neuro-Psiquiatria
|
April 12, 2001
[Continuing education in in neurology through the INTERNET]
O M Takayanagui, G D Rabello, M V Ribeiro, et al.
Hepatology (Baltimore, Md.)
|
June 10, 1998
Detection of reovirus RNA in hepatobiliary tissues from patients with extrahepatic biliary atresia and choledochal cysts
K L Tyler, R J Sokol, S M Oberhaus, et al.
Organic & Biomolecular Chemistry
|
March 23, 2007
Substituent effects on aromatic stacking interactions
Scott L Cockroft, Julie Perkins, Cristiano Zonta, et al.
Chest
|
March 1, 1996
Correlative assessment of morphologic, immunophenotypic, and genetic changes in bronchial epithelium of tobacco smokers
W A Franklin, S Todd, R M Gemmill, et al.
Journal of Medicinal Chemistry
|
March 31, 2006
Novel, achiral 1,3,4-benzotriazepine analogues of 1,4-benzodiazepine-based CCK(2) antagonists that display high selectivity over CCK(1) receptors
Iain M McDonald, Carol Austin, Ildiko M Buck, et al.
Journal of Medicinal Chemistry
|
September 14, 2007
Discovery and characterization of novel, potent, non-peptide parathyroid hormone-1 receptor antagonists
Iain M McDonald, Carol Austin, Ildiko M Buck, et al.
Journal of Medicinal Chemistry
|
October 28, 2005
Optimization of the in vitro and in vivo properties of a novel series of 2,4,5-trisubstituted imidazoles as potent cholecystokinin-2 (CCK2) antagonists
Ildiko M Buck, James W Black, Tracey Cooke, et al.
Cell Stem Cell
|
March 7, 2020
MAP4K4 Inhibition Promotes Survival of Human Stem Cell-Derived Cardiomyocytes and Reduces Infarct Size In Vivo
Lorna R Fiedler, Kathryn Chapman, Min Xie, et al.
Page
of 9